Modulation of cell surface lectin receptors on K562 human erythroleukemia cells induced by transfection with annexin IV cDNA  by Satoh, Ayano et al.
FEBS 18306 FEBS Letters 405 (1997) 107-110 
Modulation of cell surface lectin receptors on K562 human 
erythroleukemia cells induced by transfection with annexin IV cDNA 
Ayano Satoha, Eiji Takayamab, Kyoko Kojimaa, Haruko Ogawaa, Yoshimoto Katsurac, 
Tatsuo Kinac, Tatsuro Irimurad, Isamu Matsumotoa'* 
8Department of Chemistry, Faculty of Science, Ochanomizu University, Otsuka 2-1-1, Bunkyo-ku, Tokyo 112, Japan 
^'National Defense Medical College, Namiki 3-2, Tokorozawa-shi, Saitama 359, Japan 
': Department of Molecular Pathology and Immunology, Chest Disease Research Institute, Kyoto University, 
Shogoin-Kawaramachi 53, Sakyo-ku, Kyoto 606, Japan 
d Division of Cancer Biology and Molecular Immunology, Faculty of Pharmaceutical Sciences, 
The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113, Japan 
Received 17 January 1997; revised version received 6 February 1997 
Abstract Annexin IV was found to be highly expressed in 
various human adenocarcinoma cell lines, but not in an 
erythroleukemia cell line, K562. We investigated the effects of 
transfection of human annexin IV cDNA into K562 cells on cell 
surface lectin receptors. cDNA transfectants were found to be 
more sensitive to cytotoxic lectins such as Ricinus communis 
agglutinin and wheat germ agglutinin than mock transfectants. 
The results of flow cytometric analyses with various lectins 
showed that the transfectants expressed more sugar chains which 
bind to Ulex europaeus agglutinin I and Maackia amuvensis 
mitogen than mock transfectants. These results suggest that 
transfection of annexin IV cDNA increases the expression of 
a-2,3-sialylated and/or fucosylated sugar chains on the surface. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Annexins are a family of structurally related proteins that 
bind to phospholipids in a calcium-dependent manner. An-
nexins are composed of 4 or 8 repeating domains of around 
70 amino acids and an N-terminal domain specific for each 
type. The fact that annexins have no signal peptide confirmed 
findings that they are abundant in the cytoplasm, and that 
they are intracellular proteins. However, a number of recent 
studies have indicated that annexins exist not only in the 
cytoplasm, but also in the plasma membrane as intrinsic mem-
brane proteins on the cell surface, or that they are extracell-
ularly secreted, depending on the cell type. Although a num-
ber of in vitro experiments have indicated that some annexins 
either exhibit membrane channel activity, inhibit phospholip-
ase A2 and blood coagulation, transduce mitogenic signals, or 
are involved in the membrane-cytoskeleton interaction or 
membrane-related intracellular events such as vesicle trans-
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port (reviewed by Raynal and Pollard [1]), their exact biolog-
ical functions in vivo have not yet been completely elucidated. 
The effect of annexin transfection into cells which do not 
express the corresponding annexin may be useful for elucidat-
ing the function of annexins. So far, transfection studies in-
volving the cDNAs of annexins I, II and VI have been re-
ported for some cell lines. The results obtained suggest 
various properties of annexins, a relationship between annexin 
I expression and prostaglandin production in arachidonic acid 
metabolism [2], a relationship between annexin II expression 
and the expression level or translocation of p l i [3-5], an 
interaction between annexin II and tissue plasminogen activa-
tor [6], a relation between annexin II expression and osteoclast 
formation or bone résorption [7], and a relationship between 
annexin VI and cell proliferation or endocytosis of transferrin 
receptors [8,9]. 
In this study, we focused especially on the effects on the 
sensitivities to plant lectins and the cell surface expression of 
the lectin receptors of the transfection of human annexin IV 
c D N A into the human erythroleukemia cell line, K562, which 
expresses no annexm IV m R N A . 
2. Materials and methods 
2.1. Cell culture 
The human erythroleukemia cell line, K562, was donated by the 
Japan Cancer Research Resource Bank (Tokyo, Japan). K562 cells 
were grown in RPMI 1640 medium supplemented with 10% heat-in-
activated fetal calf serum without antibiotics at 37°C under a humidi-
fied atmosphere containing 5% CO2. At 70% confluency, the cells 
were passaged by dilution in fresh medium. The cells used in this 
experiment were free of mycoplasma infection. 
2.2. Northern blot analysis 
For Northern blot analysis, human annexin IV 2.0 kb cDNA from 
a human colon carcinoma cell line, a HT29 A.gtlO cDNA library [10], 
was used as a probe. A 32P-labeled probe was generated by random 
priming using Klenow fragment (Stratagene, La Jolla, CA). Blots 
were hybridized and washed according to the procedure described 
by Church and Gilbert [11]. 
2.3. cDNA transfection and production of stable transfectants 
cDNA was ligated into the Hindlll-Kpnl site of expression vector 
pCEP4 (Invitrogen, San Diego, CA). Plasmid DNA was purified using 
a plasmid DNA purification kit (Qiagen GmbH, Germany). Actively 
proliferating K562 cells were harvested, washed, and then resuspended 
in standard phosphate-buffered saline (PBS) at 1 X 107 cells/ml in 0.4 
cm cuvettes (Bio-Rad Labs, Hercules, CA) in a total volume of 0.4 ml. 
Electroporation (Bio-Rad Gene puiser) with purified plasmid DNA (5 
(ig) was performed at 400 V (250 uF), with a time constant consis-
tently in the range of 5.6-5.9 ms. Transfected cells were selected in 
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medium containing hygromycin B (Calbiochem, San Diego, CA) at a 
final concentration of 400 |ig/ml after 72 h and maintained in the 
same medium thereafter. After 3 weeks, the cells were cloned by 
limited dilution. For the selection of cells expressing annexin IV, 
flow cytometric analysis and immunoprecipitation were performed. 
2.4. Preparation of cell lysates, immunoprecipitation, SDS-PAGE and 
Western blot and lectin blot analyses 
Cell lysate preparation and immunoprecipitation were performed 
according to the procedures described by Satoh et al. [10]. After in-
cubation, the immune complexes were collected, washed, and then 
analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis (PAGE) according to the procedure of Laemmli [12]. After 
electrophoresis, the gel was stained with Coomassie brilliant blue 
(CBB). For Western blot and lectin blot analyses, after electrophore-
sis, the separated proteins were electroblotted onto polyvinylidene 
difluoride membranes (Millipore, Bedford, MA). The membranes 
were first blocked with 1% bovine serum albumin (BSA) and then 
incubated with a biotinylated lectin at a final concentration of 10 
ug/m at room temperature for 1 h. Each blot was washed three times 
and subsequently incubated with horseradish peroxidase (HRP)-con-
jugated biotin and avidin complex (Vector Labs, Burlingame, CA) at 
a final dilution of 1:100 at room temperature for 1 h. The membrane 
was washed three times and then developed with 0.5 mg/ml 4-chloro-
1-naphthol containing 0.01% hydrogen peroxide. 
2.5. Flow cytometric analysis 
All the procedures were performed at 4°C. For cytoplasmic staining 
on flow cytometric analysis, cells were fixed with 1% formalin and 
then permeabilized with 0.1% Triton X-100. The cells were washed 
with PBS, incubated with monoclonal antibody AS 17 at a final con-
centration of 1 Ug/ml with 0.5% BSA for 30 min, washed with PBS, 
and then incubated with fluorescein isothiocyanate (FITC)-conjugated 
anti mouse IgG (Cappel Labs., Durham, NC) at a final dilution for 
1:200 for 30 min. For analysis of cell surface sugar chains, untreated 
cells were incubated with biotinylated lectins (Seikagaku Co., Tokyo, 
Japan) with 0.5% BSA, for 30 min at a final concentration of 10 ug/ 
ml, washed with PBS containing 0.5% BSA and then incubated with 
avidin DCS-FITC (Vector) at a final dilution for 1:200 for 20 min. 
The cells were washed with PBS containing 0.5%> BSA and then re-
Fluorescence intensity 
Fig. 2. Expression of annexin IV in transfected K562 cells. Cells ex-
pressing annexin IV were subjected to flow cytometric analysis. The 
cytoplasms of annexin IV cDNA transfectants (annexin IV), vector 
only transfectants (mock), and normal K562 cells (K562) were 
stained with monoclonal antibody AS 17. 
suspended in 100 ul of PBS. Flow cytometric analysis was performed 
using a flow cytometer, model Cyto ACE (Jasco, Tokyo, Japan). The 
excitation wavelength was 488 nm with an argon-ion laser, and green 
fluorescence from FITC collected through a 530 nm band-pass filter 
was measured on a log scale. Controls consisted of cells treated with 
normal mouse IgG or without biotinylated lectins. 
2.6. Reverse transcriptase-mediated polymerase chain reaction analysis 
of a-2,3-sialyltransferases 
Total RNA was extracted from 5X106 cells. First-strand cDNA 
was synthesized with an oligodeoxythymidylic acid primer and avian 
myeloblastosis virus reverse transcriptase (Life Sciences, St. Peters-
burg, FL) from 1 ug of total RNA in a total volume of 100 til. 
Second-strand synthesis and amplification were carried out on 1 ul 
of the first-strand reaction mixtures for sialyltransferase (ST3 and 
ST4, [13,14]) amplifications and 0.1 ul for ß-actin amplification. The 
reaction mixtures contained 25 pmol of primers and 5 units of Taq 
DNA polymerase. Thirty amplifications were performed. Each cycle 
consisted of 1 min at 94°C, 2 min at 55°C and 2 min at 72°C. Aliquots 
of each reaction mixture were separated by 1%> agarose gel electro-
phoresis. Control PCR reactions were also performed on the first-
strand cDNA which had been prepared without reverse transcriptase 
to exclude the possibility of amplification of contaminating genomic 
DNA. No amplification of contaminating genomic DNA was de-
tected. The sizes of the fragments amplified from ST3 and ST4 were 
481 base pairs (50-530) and 402 base pairs (579-582), respectively, 
with synthetic oligonucleotide primer. 
3. Results and discussion 
Fig. 1. Northern analysis of annexin IV mRNA. 10 |xg of total 
RNA from human colon adenocarcinoma cell line HT29 and hu-
man erythroleukemia cell line K562, respectively, was hybridized 
with the human annexin IV 2.0 kb cDNA. RNA species of 2.0 kb 
and 3.0 kb were detected for HT29 but not for K562 cells (a). The 
RNA was stained with ethidium bromide in the gel prior to blotting 
(b). 
The size of the m R N A encoding annexin IV was deter-
mined by Nor thern blot analysis. Total R N A s from human 
colon cancer cell line HT29 and human erythroleukemia cell 
line K562 were separated in an agarose gel containing formal-
dehyde, blotted onto a Gene Screen Plus membrane (DuPont 
N E M Products, Boston, MA), and subsequently hybridized 
with a probe prepared with human annexin IV 2.0 kb 
cDNA. The 2.0 kb annexin IV c D N A sequence data are avail-
able in the EMBL/GenBank D D B J under accession number 
D78152. Total R N A of HT29 gave strongly stained bands at 
about 2.0 kb and 3.0 kb, but R N A from K562 showed no 
staining (Fig. 1). 
K562 cells were transfected with annexin IV cDNA, since 
K562 cells do not express either annexin IV m R N A s (Fig. 1) 
or protein. The annexin IV c D N A transfectants were found to 
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Fig. 3. Lectin toxicity in K562 cell transfectants. Annexin IV cDNA 
transfectants (annexin IV) and mock transfectants (mock) were 
treated with biotinylated lectins, and then the cells were analyzed by 
Cyto ACE. The viable cell numbers are presented as percentages of 
total cells. The values are means of the results of three experiments. 
express annexin IV on flow cytometric analysis with mono-
clonal antibody AS 17 (Fig. 2). The transfectants were cloned 
by limited dilution, and annexin IV expression was confirmed 
by immunoprecipitation using AS 17. 
The annexin IV cDNA transfectants of K562 were found to 
be slightly more adhesive to culture dishes compared to the 
wild type and mock transfectants (data not shown), suggesting 
that cell surface molecules changed on annexin IV cDNA 
transfection. Previously, we reported that annexin IV exhibits 
calcium-dependent carbohydrate binding activity [10,15-17]. 
Furthermore, not only annexin IV but also annexins V and 
VI were found to have carbohydrate binding properties with 
different specificities [18,19]. Therefore, we examined whether 
or not cell surface sugar chains changed on annexin IV cDNA 
transfection. The transfectants and mock transfectants were 
treated with biotinylated lectins and then subjected to flow 
cytometric analysis. The cells expressing annexin IV were 
more sensitive to Ricinus communis agglutinin (RCA 120) 
and wheat germ agglutinin (WGA) than mock transfectants 
(Fig. 3). The sensitivities of annexm IV transfectants to 
RCA120 and WGA were 3.3 and 2.8 times greater than those 
of mock transfectants, respectively. RCA 120 and WGA are 
well-known as cytotoxic lectins that induce tumor cell apop-
tosis [20]. The increased sensitivities may have been caused by 
an increase of these lectin receptors on the cell surface. How-
ever, since the numbers of lectin receptors were similar in 
annexin IV and mock transfectants (Fig. 4), the increased 
sensitivities must be caused by activation of the endocytic 
pathway, described below. Some annexins have been reported 
to be involved in the endocytic pathway. Annexin VI is re-
quired for coated-vesicle budding, whereas annexin II plays a 
role in endosomal fusion [21]. It seemed possible that annexin 
IV may also be involved in the endocytic pathway as annexin 
II and annexin VI are. The endocytic pathway including li-
gand-receptor complex uptake and/or endosomal vesicle fu-
sion may be activated by annexin IV transfection. 
Furthermore, the transfectants expressed more sugar chains 
which bind to Ulex europaeus agglutinin I (UEA-I) and 
Maackia amurensis mitogen (MAM), which recognize oe-1,2-
fucosylated and oc-2,3-sialylated chains, than mock transfec-
tants (Fig. 4). The expression of UEA-I and MAM by annex-
in IV transfectants was 1.9 and 2.1 times greater than that by 
mock transfectants, respectively. MAM binds to sialyl-a-2,3-
linked galactosides on tri- and tetra-antennary oligosacchar-
ides [22]. Annexin IV binds not only to glycosaminoglycans 
but also to sialoglycoproteins such as calf fetuin [15], which 
has three TV-linked sugar chains containing highly sialylated 
tri-antennary oligosaccharides [23]. To identify the proteins 
that act as endogenous annexin IV ligands, we performed 
lectin blot analysis of the transfectants and found that a sia-
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Fig. 4. Differences in cell surface carbohydrate between annexin IV cDNA transfectants and mock transfectants. Annexin IV cDNA transfec-
tants (annexin IV) and mock transfectants (mock) were treated with biotinylated lectins, and then the cells were analyzed by Cyto ACE. The 
data presented are the mean fluorescence intensities on a logarithmic scale of the viable populations of transfected cells. The values are means 
of the results of three experiments. 
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lylated ( M A M reactive) glycoprotein of 65 k D a in size was 
expressed at a slightly higher level by the transfectants than in 
mock transfectants (data not shown). However, this difference 
alone cannot explain the results of flow cytometric analysis 
with M A M . The increase in sialylated and fucosylated sugar 
chain expression observed following annexin IV transfection 
may occur for the following reasons: (i) the sialylated and/or 
fucosylated glycoproteins may be protected from proteolytic 
degradation on binding with annexin IV; (ii) the cell surface 
expression of the sialylated and/or fucosylated sugar chains 
may be increased by membrane-related events such as exocy-
tosis and vesicle transport , in which annexin IV is involved; 
and (iii) the surface sugar chains may be more sialylated and/ 
or fucosylated due to increased sialyltransferase/fucosyltrans-
ferase expression and activity. Some sialyl-a-2,3-linked galac-
toside sialyltransferases have been cloned and characterized 
[13,14,24,25]. We therefore examined whether or not sialyl-
a-2,3-linked galactoside sialyltransferase expression is in-
creased by annexin IV transfection using RT-PCR methods, 
but no significant difference was found between the annexin 
transfectants and mock transfectant and normal K562 cells 
(data not shown). 
Further work is required to determine how annexin IV 
transfection increases the cell surface expression of sialylated 
and/or fucosylated sugar chains and, furthermore, whether or 
not direct interaction between annexin IV and the sialylated 
glycoproteins is involved in the increased surface expression. 
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